Clinical trial

Effectiveness and Safety Study of Pentosan Polysulfate Sodium for the Treatment…

NCT00086684 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry · Terminated

Key facts

NCT number NCT00086684
Title Effectiveness and Safety Study of Pentosan Polysulfate Sodium for the Treatment of Interstitial Cystitis
Official title Randomized, Double-Blind, Placebo-Controlled, Parallel Group Evaluation of the Efficacy and Tolerability of Two Different Doses of ELMIRON for the Treatment of Interstitial Cystitis
Lead sponsor Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry
Status Terminated
Phase Phase 4
Study type Interventional
Conditions Interstitial Cystitis
Intervention type Drug
Interventions Pentosan polysulfate sodium 100 mg, Placebo
Enrollment 369
Start date Sep 1, 2003
Primary completion Jun 1, 2011
Completion Jun 1, 2011
First posted Jul 9, 2004
Last update posted Apr 21, 2014
Countries Canada, United States

At a glance

  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies